Description
Tesamorelin is a synthetic 44-amino acid analog of endogenous growth hormone-releasing hormone (GHRH). Engineered for enhanced stability while maintaining high affinity for the GHRH receptor, Tesamorelin is widely utilized in laboratory research investigating endogenous growth hormone signaling, IGF-1 regulation, metabolism, and endocrine physiology.
Unlike exogenous growth hormone, Tesamorelin functions by stimulating the body’s natural release of growth hormone through activation of GHRH receptors located in the anterior pituitary. This makes it a valuable research compound for studying pulsatile growth hormone secretion and the downstream biological pathways influenced by growth hormone and insulin-like growth factor-1 (IGF-1).
Areas of Scientific Research
Tesamorelin has been investigated in numerous preclinical and clinical studies involving:
- Growth hormone secretion and endocrine signaling
- IGF-1 regulation
- Lipid and fat metabolism
- Visceral adipose tissue biology
- Body composition research
- Mitochondrial and metabolic function
- Healthy aging pathways
- Hepatic lipid metabolism
- Exercise physiology
- Recovery and tissue remodeling
Researchers continue to explore how endogenous growth hormone influences metabolism, protein turnover, energy utilization, and cellular function across multiple biological systems.
Mechanism of Action
Tesamorelin binds to growth hormone-releasing hormone receptors located on pituitary somatotroph cells. Activation of these receptors stimulates the physiological release of endogenous growth hormone, which subsequently increases circulating IGF-1 concentrations. This signaling cascade provides researchers with an effective model for studying growth hormone-mediated metabolic regulation while preserving the body’s normal pulsatile hormone release patterns.
Research Interest
Tesamorelin has become one of the most extensively studied GHRH analogs because of its high receptor specificity, improved stability, and well-characterized pharmacology. Scientific literature has examined its effects on:
- Growth hormone physiology
- Fat distribution
- Metabolic biomarkers
- Body composition
- Insulin sensitivity
- Hepatic fat metabolism
- Lipid utilization
Its established research profile has made Tesamorelin a frequently selected compound for investigators studying endocrine regulation and metabolic health.
Product Specifications
- Compound: Tesamorelin
- Quantity: 10 mg
- Appearance: Lyophilized powder
- Purity: ≥99% (batch-specific COA available)
- Storage: Store refrigerated. For long-term storage, freezing is recommended.
- Administration: For laboratory research use only.
Quality Commitment
Every Crownwell Research batch is manufactured under stringent quality standards and undergoes identity and purity verification. Batch-specific Certificates of Analysis (COAs) are available to support research integrity and reproducibility.
Disclaimer
FOR RESEARCH USE ONLY.
This product is intended solely for laboratory and scientific research by qualified professionals. It is not intended for human consumption, therapeutic use, veterinary use, or diagnostic purposes. Crownwell Research products are not drugs, foods, cosmetics, or dietary supplements and have not been evaluated by the FDA for safety or efficacy.
